Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited

KREBSBIO.NS
Krebs Biochemicals & Industries LimitedIN flagNational Stock Exchange of India
58.49
INR
-0.06
- -
1.26BMarket Cap

Krebs Biochemicals & Industries Limited (KREBSBIO.NS) Stock Split History

Learn about Krebs Biochemicals & Industries Limited's most recent 207-for-200 basis stock split on January 31, 2019. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Krebs Biochemicals & Industries Limited's most recent stock split

Split Date: 2019-01-31
Split Ratio: 207:200
Price Before Split: $101.12
Price After Split: $97.70

Developer API

Get KREBSBIO.NS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/KREBSBIO.NS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.03 times more shares (a 207:200 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Krebs Biochemicals & Industries Limited's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2019-01-31207:200No$101.12$97.70

About Krebs Biochemicals & Industries Limited

Company overview and industry information

Krebs Biochemicals & Industries Limited (KREBSBIO.NS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 207-for-200 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Krebs Biochemicals & Industries Limited Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.